Illegal Activity
none
Blackmail
none
Date
2014-04-02
Document Type
financial_report
Model
gemini-2.0-flash-001
Processed
2026-02-07T18:42
Summary
This document is a financial report detailing the performance of an investment portfolio in biotech companies as of April 2, 2014. It lists the trade date, quantity, current price, unit cost, market value, current total cost, and unrealized gain/loss for each stock.
Metadata
- Subject
- Investment Portfolio
- Sender
- —
- Recipients
- —
- Document ID
- DB-SDNY-0101745
- Date
- 2014-04-02
Financial Information
Amounts:17.518.44875,500.00422,214.00453,286.00308.71119.55646,747.45250,454.95396,292.5031.6227.51790,500.00687,663.50102,836.5073.7979.41597,699.00643,204.00(45,505.00)3,043,139.832,294,533.85906,910.008.0317.60132,693.38290,997.40(158,304.03)
Assets:
- SANGAMO BIOSCIENCES
- BIOGEN
- FOUNDATION MEDICINE
- GILEAD SCIENCES INC
- ARIAD PHARMACEUTICALS
Raw Analysis JSON
click to expand
Themes
Financial transactions/money flow
Organizations 5
SANGAMO BIOSCIENCESBIOGENFOUNDATION MEDICINEGILEAD SCIENCES INCARIAD PHARMACEUTICALS
Text Analysis
- Tone
- Informative
- Purpose
- To provide a snapshot of an investment portfolio's performance as of a specific date.
- Significance
- This document provides a financial overview of biotech investments, including market value and unrealized gains/losses.
File Info
- File Name
- EFTA01447189.txt
- Dataset
- dataset_10
- Type
- Text
- Model
- gemini-2.0-flash-001
- Processed
- 2026-02-07T18:42:29.867151
- DOJ Source
- View on DOJ